Physician profile
Martin Malachovsky
NPI 1568402261
$532.30
in general payments reported to CMS, 2019-2025
11 companies · $38.02 in 2025
The $38.02 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2021: $38.08 · 2022: $37.94 · 2023: $167 · 2024: $52.60 · 2025: $38.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $134.89 | 2019 | |
| Pfizer INC. | $129.91 | 2022-2025 | |
| Heartflow, INC. | $101.62 | 2023 | Ffrct |
| Abbvie INC. | $33.27 | 2019 | |
| Exact Sciences Corporation | $23.97 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $20.81 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $20.32 | 2023 | |
| Kaleo, INC. | $20.06 | 2022 | |
| Seqirus USA INC | $17.27 | 2021 | |
| Shire North American Group INC | $15.96 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Malachovsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.